Merck & Co Inc
NYSE: MRK
$99.85
-$1.17 (-1.2%)
Closing Price on January 8, 2025
MRK Articles
Pharmaceutical maker Merck beat adjusted earnings estimates but missed slightly on revenues when it reported Q3 results Thursday morning. Investors responded positively, however.
Published:
Last Updated:
These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices for worried investors to consider...
Published:
Last Updated:
24/7 Wall St. has put together a preview of Boeing, Intel, Verizon and the other Dow companies scheduled to report their quarterly results this week.
Published:
Last Updated:
Apple shares dipped again last week, but the company managed to hold onto its rank as the top-performing Dow stock for the year to date. Shares are up nearly 30% in 2018.
Published:
Last Updated:
Merck shares were up handily on Tuesday after the company announced a key update from the FDA on its Lynparza for the treatment of pancreatic cancer.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday included Adobe, Bank of America, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX Companies and Valero Energy.
Published:
Last Updated:
Apple survived a bloody week in the markets to return as the best-performing Dow Jones industrial stock for the year to date.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Abercrombie & Fitch, CME, Costco, DowDuPont, Gap, HCA, Herbalife, Merck, PayPal and Urban Outfitters.
Published:
Last Updated:
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the remainder of October.
Published:
Last Updated:
These five well-known stocks may be laggards but they look like they have solid upside potential, and all can help add alpha to portfolios.
Published:
Last Updated:
Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of October.
Published:
Last Updated:
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Nike's risky new ad campaign featuring NFL player Colin Kaepernick has paid off in higher sales and increased attention from analysts who have raised ratings and price targets and said lots of nice...
Published:
Last Updated:
Apple, IBM, Merck, and Travelers buoyed the Dow index on Thursday.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.